Dr. Devi Vedula M.D.

Recommended Articles

• Cystic Fibrosis: Talking to Loved Ones

  When getting a life-changing diagnosis, it may be hard to discuss it with others. It is isolating when you feel others do not understand; your family and friends may not have cystic fibrosis or know people affected by the disease. You may also be dealing with shock from the new diagnosis. Chances...

• How Family Can Be a Powerful Support System for Those with Cystic Fibrosis

  Family can be a powerful support system. People are naturally community-driven beings who are healthiest and happiest when belonging to something greater. It's the reason that people will make great sacrifices for the people they love. Family can provide the pillar for emotional support through...

• Is Pleurisy Contagious?

  Our lungs are separated from the chest cavity by a very thin membrane that folds onto itself, forming a two-layered membrane known as the pleura. Between the two layers is a small cavity known as the pleural membrane.This cavity is filled with a small quantity of lubricating fluid, the primary...

• Colorado Family Raises Awareness to Find Cystic Fibrosis Cure

  Before, during, and after having a baby, time is spent stressing about getting all the things the baby will need, thinking about whether the nursery will be done on time, and lots of time is spent worrying whether the baby will be healthy or not. This worst fear of many moms and dads came true for...

• Everything You Need to Know About Bronchitis

  Bronchitis is a common medical condition affecting people worldwide, regardless of their age and sex. However, bronchitis tends to affect young children and infants, as well as people who have chronic medical conditions, especially chronic conditions affecting the lungs and heart.Bronchitis is an...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...